Contact Us  





Division of Medical Oncology
University of Colorado Denver
12801 E. 17th Avenue
Aurora, CO  80010
Ph:  (303) 724-3888
Fax:  (303  724-3889
info@deptofmed.edu


 



Anthony D. Elias, M.D.
Professor
Division of Medical Oncology

Education: New York University
School of Medicine, New York, NY – 1980

University of Colorado Denver
School of Medicine
Division of Medical Oncology
Tel: (720) 724-3808
Fax: (720) 848-1620
Emial: anthony.elias@uchsc.edu


Bio
Since arriving in 1991, Dr. Elias' focus has been on experimental therapeutics for breast cancer, describing molecular changes associated with anti-estrogen and/or chemotherapy drug resistance and tissue banking for breast cancer.  Another interest is experimental therapy for sarcomas.

Research
Dr. Elias is focused on clinical breast cancer research and is the director of the clinical breast oncology program. This comprehensive program includes a weekly multi-disciplinary clinic and tumor board, a hereditary clinic, benign breast complaint clinic, a screening and breast imaging program, in addition to daily breast specialty oncology clinics.  The sarcoma program includes consult/new patient clinics as well as followups.  Dr. Elias is the principal investigator on numerous national and local therapeutic trials and is institution PI for the SWOG grant.  He is a member of the SWOG breast committee. He is also the Associate Director of the Cancer Center for clinical sciences and oversees the Clinical Investigations Core. 

 

FACULTY LIST

Lynn Bemis
Virginia Borges
Paul Bunn
David Calverley
Ross Camidge
Dan Chan
Gail Eckhardt
Anthony Elias
Thomas Flaig
Marileila Garcia
L. Michael Glode
Rene Gonzalez
Barb Helfrich
Fred Hirsch
Christopher Hogan
Antonio Jimeno
Madeleine Kane
Choon-Kee Lee
Stephen Leong
Wells Messersmith
Han Myint
Ana Oton
Peter Raich
William Robinson
Pepper Schedin
John Tentler
William Tse
Colin Weekes

Publications
Ramaswamy B, Elias AD, Kelbick N, Morrow M, Hauger M, Rhoades C, Kendra K, Allen J, Chen H, Eckhardt G, Shapiro CL.  Phase II Trial of Bevazicumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients.  Clin Cancer Res 2006; 12: 3124-3129.

Moore HCF, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow W, Hudis C, Wolff AC, Ingle JN, Gandara DR, Elias AD, Livingston RB, Martino S.  Intensive Dose-Dense Versus High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer:  Southwest Oncology Group/Intergroup Study 9623.  J Clin Oncol 2007; 25: 1677-1682.

Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff, AC, Eisenberg PD, Lehman M, Adams BJ, Baum CM, Miller KD.  A phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.  J Clin Oncol, submitted.

Funding
SWOG
Pfizer
Roche
Other Pharmag

PubMed articles

BACK TO TOP




Home  |  About  |  Faculty  |  Staff  |  Research  |  Clinical Trials  |  Fellowship 
Make a Donation  |  Employee Resources  |  Patient Information  |  Calendar
 
 
  Division of Medical Oncology
Copyright © 2008 University of Colorado Denver

Privacy Practices  
ds="14,39,391,97" href="../index.htm" />